Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F E Lund

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Experimental Medicine|December 1, 1991
Regulated expression of mouse mammary tumor proviral genes in cells of the B lineageF E Lund, R B Corley
Current Biology : CB|October 1, 1991
Who's zooming who?R B Corley, F E Lund
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1993
MHC class II limits the functional expression of endogenous superantigens in B cellsF E Lund, T D Randall, D L Woodland, et al.
Blood|May 15, 1996
Expression of murine CD38 defines a population of long-term reconstituting hematopoietic stem cellsT D Randall, F E Lund, M C Howard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1996
Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expressionF E Lund, N Yu, K M Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1990
Molecular events in B lymphocyte differentiation. Inducible expression of the endogenous mouse mammary tumor proviral gene, Mtv-9L B King, F E Lund, D A White, et al.
The Journal of Experimental Medicine|July 1, 1992
Major histocompatibility complex-restricted recognition of retroviral superantigens by V beta 17+ T cellsM A Blackman, F E Lund, S Surman, et al.
Immunological Reviews|April 29, 1998
CD38: a new paradigm in lymphocyte activation and signal transductionF E Lund, D A Cockayne, T D Randall, et al.
Molecular and Cellular Biology|July 1, 1993
Interleukin-5 (IL-5) and IL-6 define two molecularly distinct pathways of B-cell differentiationT D Randall, F E Lund, J W Brewer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 1999
CD38 signaling in B lymphocytes is controlled by its ectodomain but occurs independently of enzymatically generated ADP-ribose or cyclic ADP-riboseF E Lund, H M Muller-Steffner, N Yu, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Experimental Medicine|December 1, 1991
Regulated expression of mouse mammary tumor proviral genes in cells of the B lineageF E Lund, R B Corley
Current Biology : CB|October 1, 1991
Who's zooming who?R B Corley, F E Lund
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1993
MHC class II limits the functional expression of endogenous superantigens in B cellsF E Lund, T D Randall, D L Woodland, et al.
Blood|May 15, 1996
Expression of murine CD38 defines a population of long-term reconstituting hematopoietic stem cellsT D Randall, F E Lund, M C Howard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1996
Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expressionF E Lund, N Yu, K M Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1990
Molecular events in B lymphocyte differentiation. Inducible expression of the endogenous mouse mammary tumor proviral gene, Mtv-9L B King, F E Lund, D A White, et al.
The Journal of Experimental Medicine|July 1, 1992
Major histocompatibility complex-restricted recognition of retroviral superantigens by V beta 17+ T cellsM A Blackman, F E Lund, S Surman, et al.
Immunological Reviews|April 29, 1998
CD38: a new paradigm in lymphocyte activation and signal transductionF E Lund, D A Cockayne, T D Randall, et al.
Molecular and Cellular Biology|July 1, 1993
Interleukin-5 (IL-5) and IL-6 define two molecularly distinct pathways of B-cell differentiationT D Randall, F E Lund, J W Brewer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 1999
CD38 signaling in B lymphocytes is controlled by its ectodomain but occurs independently of enzymatically generated ADP-ribose or cyclic ADP-riboseF E Lund, H M Muller-Steffner, N Yu, et al.
Pageof 3